a Biovitrum AB, Department of Medicinal Chemistry, Rapsgatan 7, Uppsala 751-37, Stockholm, Sweden
b Biofocus Plc., Sittingbourne, UK
c Pharmacia Corporation, Nerviano, Italy
Abstract:
A series of 5-substituted 2-benzoylaminobenzoic acids has been synthesized and assayed for PPAR/γ activity. Both dual activators and selective PPARγ agonists have been identified. This class of compounds was shown to activate the PPARγ receptor through interaction with a novel binding site.